MCULE-1218109825
- InChIKey:
- SMILES:
- InChI:
- Formula:
Amount | Price
Optimized compound price excluding delivery costs. Please note that automatic quote generation will optimize the total price based on your preferences.
|
Guaranteed purity (%) | Delivery time
Estimated door-to-door delivery time for EU and US customers. It will be refined and optimized during quote generation after the shipping country is specified.
|
|
---|---|---|---|---|
1 mg | 12 USD | 98 | 20 working days | Get Quote |
5 mg | 12 USD | 98 | 20 working days | Get Quote |
10 mg | 12 USD | 98 | 20 working days | Get Quote |
- 1-Click Docking Predict the binding orientation and affinity of the ligand to a target.
- Toxicity checker Searching for substructures commonly found in toxic and promiscuous ligands.
- Property calculator Create a physicochemical property profile for the compound in a second.
- Similarity search Find analogs by similarity search.
- Substructure search Find analogs by substructure search.
Name | File |
---|---|
SDF | MCULE-1218109825.sdf |
SMILES | MCULE-1218109825.smiles |
Standard InChI | MCULE-1218109825.inchi |
InChIKey | MCULE-1218109825.txt |
mcule product ID | Supplier | Catalog | Guaranteed purity (%) | Product matching | Availability |
---|---|---|---|---|---|
P-872826964 | A2B Chem | Predominantly Building Block in stock | 98 | As is | in stock |
P-875734947 | AA Blocks | AA Blocks - in stock | N/A | As is | in stock |
P-505401203 | AK Scientific | Building Blocks | 98 | As is | in stock |
P-517095583 | Alinda | Stock Screening Compounds | 90 | As is | in stock |
P-893292503 | AmBeed | In stock | N/A | As is | in stock |
P-865908806 | Angene | Building Blocks in stock | 98 | As is | 50 g |
P-864175599 | AstaTech | In Stock BBs | 98 | As is | in stock |
P-448676752 | ChemDiv | Discovery Chemistry Library | 90 | As is | 96 mg |
P-861339317 | Combi-Blocks | Building Block on demand | 95 | As is | by synthesis |
P-488545789 | InterBioScreen | Building Blocks | 90 | As is | in stock |
P-12586440 | InterBioScreen | Screening Compounds | 92 | As is | unavailable |
P-588251046 | Manchester Organics | Compounds on demand | N/A | As is | by synthesis |
P-852608936 | Matrix Scientific | All | N/A | As is | in stock |
P-899989058 | MedChemExpress | Screening compounds on demand | 95 | As is | by synthesis |
P-869014606 | MedChemExpress | Building Blocks on demand | 95 | As is | by synthesis |
P-871073775 | MedKoo | In stock compounds | 95 | As is | in stock |
P-454365855 | Pharmeks LLC | Building Blocks | 92 | As is | in stock |
P-864659967 | Pharmeks LLC | Synthetic compounds | 92 | As is | 300 mg |
P-23851699 | Princeton Biomolecular Research | Screening Compounds | 90 | As is | in stock |
P-885524320 | Princeton Biomolecular Research | Building Blocks Synthesis | 95 | As is | by synthesis |
P-12497687 | Specs | Screening Compounds | 90 | As is | 82 mg |
P-869125597 | TargetMol | Screening Compounds - synthesis | 95 | As is | by synthesis |
P-888639149 | TargetMol | Screening Compounds - stock amount | 95 | As is | unavailable |
P-888592037 | TimTec | ActiMol 4 Week - On demand | 94 | As is | by resynthesis (? - ? days) |
P-611581535 | Toronto Research | In stock | 90 | As is | in stock |
P-1866517 | VITAS M CHEMICAL LIMITED | Screening compounds | 90 | As is | 1.536 g |
P-3229484 | VITAS M CHEMICAL LIMITED | Organic Building Blocks | 90 | As is | 1.536 g |
P-667024387 | eNovation Chemicals LLC | Building Blocks in stock | 95 | As is | in stock |
Property | Value |
---|---|
Components | 1 |
Mass | 183.069 |
logP | 0.6868 |
H-bond acceptors | 2 |
H-bond donors | 0 |
Rotatable bonds | 0 |
PSA | 25.78 |
RO5 violations | 0 |
RO3 violations | 0 |
Refractivity | 36.478 |
Atoms | 13 |
Rings | 2 |
Heavy atoms | 9 |
Hydrogen atoms | 4 |
Heteroatoms | 3 |
N/O atoms | 2 |
Inorganic atoms | 1 |
Halogen atoms | 0 |
Chiral centers | 0 |
R/S chiral centers | 0 |
Unknown chiral centers | 0 |
Undefined chiral centers | 0 |
Stereo double bonds | 0 |
Cis/trans stereo double bonds | 0 |
Unknown stereo double bonds | 0 |
Undefined stereo double bonds | 0 |